Lisa Masucci

Toronto, ON M5G2C4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma.

A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma.

Journal: Current oncology (Toronto, Ont.)

Published: March 30, 2026

Mailed Audit and Feedback for Antibiotic Prescribing in Primary Care.

Mailed Audit and Feedback for Antibiotic Prescribing in Primary Care.

Journal: JAMA network open

Published: March 13, 2026

Comparative effectiveness of chimeric antigen receptor (CAR) T-cell therapy versus historical controls in patients with relapse/refractory aggressive B-cell lymphoma: An indirect treatment comparison in the real-world setting.

Comparative effectiveness of chimeric antigen receptor (CAR) T-cell therapy versus historical controls in patients with relapse/refractory aggressive B-cell lymphoma: An indirect treatment comparison in the real-world setting.

Journal: British journal of haematology

Published: February 25, 2026

The use of real-world evidence among healthcare payers: a scoping review.

The use of real-world evidence among healthcare payers: a scoping review.

Journal: International journal of technology assessment in health care

Published: September 12, 2025

Safety of antibiotic audit and feedback: secondary analysis of a randomized controlled trial.

Safety of antibiotic audit and feedback: secondary analysis of a randomized controlled trial.

Journal: The Journal of antimicrobial chemotherapy

Published: August 26, 2025

Cost-Effectiveness of the I'm Ready HIV Self-Testing Programme Among High-Risk Populations in Canada.

Cost-Effectiveness of the I'm Ready HIV Self-Testing Programme Among High-Risk Populations in Canada.

Journal: Journal of the International AIDS Society

Published: August 12, 2025

Impact of Chimeric Antigen Receptor T-Cell Therapy on Health Utilities of Patients Diagnosed with Diffuse Large B-Cell Lymphoma in Canada.

Impact of Chimeric Antigen Receptor T-Cell Therapy on Health Utilities of Patients Diagnosed with Diffuse Large B-Cell Lymphoma in Canada.

Journal: Transplantation and cellular therapy

Published: June 26, 2025

Real-world healthcare costs for patients treated with chimeric antigen receptor T-cell therapy in Canada.

Real-world healthcare costs for patients treated with chimeric antigen receptor T-cell therapy in Canada.

Journal: Leukemia & lymphoma

Published: June 17, 2025

Evolving landscape of economic evaluations of HIV pre-exposure prophylaxis and pre-exposure prophylaxis implementation strategies: a systematic review.

Evolving landscape of economic evaluations of HIV pre-exposure prophylaxis and pre-exposure prophylaxis implementation strategies: a systematic review.

Journal: Journal of the International AIDS Society

Published: April 07, 2025

CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis.

CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis.

Journal: Medical decision making : an international journal of the Society for Medical Decision Making

Published: March 15, 2024

Cellular therapy: Great promise, but at what cost?

Cellular therapy: Great promise, but at what cost?

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: November 15, 2022

Universal screening of newborns for biliary atresia: Cost-effectiveness of alternative strategies.

Universal screening of newborns for biliary atresia: Cost-effectiveness of alternative strategies.

Journal: Journal of medical screening

Published: March 16, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026